Novel Calcium Phosphate Promotes Interbody Bony Fusion in a Porcine Anterior Cervical Discectomy and Fusion Model.


Journal

Spine
ISSN: 1528-1159
Titre abrégé: Spine (Phila Pa 1976)
Pays: United States
ID NLM: 7610646

Informations de publication

Date de publication:
12 Jan 2024
Historique:
received: 24 10 2023
accepted: 16 12 2023
medline: 12 1 2024
pubmed: 12 1 2024
entrez: 12 1 2024
Statut: aheadofprint

Résumé

Experimental porcine anterior cervical discectomy and fusion (ACDF) model: a proof-of-concept study. The effect of monetite synthetic bone graft containing calcium pyrophosphate (Ca-PP) and β-tricalcium phosphate (β-TCP) on cervical spinal fusion in a non-instrumented two-level large animal model. ACDF is the gold standard surgical technique for the treatment of degenerative cervical spinal diseases. However, pseudarthrosis associated with increased patient morbidity occurs in approximately 2,6% of the surgeries. Synthetic bone graft (SBG) may enhance bony fusion and subsequently decrease the risk of pseudarthrosis. Recent studies on monetite-based synthetic bone grafts for use in large cranial defects in humans have shown promising bone healing results, necessitating further investigation of their use in cervical spinal fusion. Four adult female Danish Göttingen mini-pigs received partial cervical anterior discectomy and intervertebral defects at an upper and lower level. One defect was filled with SBG and the other was left empty. Bony fusion was evaluated using computed tomography (CT) at three-month intervals for 12 months. Fifteen months post-surgery, the animals were euthanized for further ex vivo qualitative histopathological and micro-CT evaluations. Fusion rates were compared using Fisher´s exact test at each time point. Increased interbody bony fusion rates were observed at synthetic bone graft levels (4/4) compared with control levels (0/4) evaluated by CT at 6- and 9-months post-surgery (P= 0.029). Fusion was observed at all synthetic bone graft levels 12 months post-surgery and at only one control level. Histopathological evaluation confirmed high-quality interbody bony fusion at all synthetic bone graft levels, and fusion by spondylosis at one control level. This proof-of-concept study provides preliminary evidence of a novel, Ca-PP -and β-TCP-containing monetite SBG that promotes bony fusion compared to a negative control in a clinically relevant porcine model of ACDF. N/A.

Sections du résumé

STUDY DESIGN METHODS
Experimental porcine anterior cervical discectomy and fusion (ACDF) model: a proof-of-concept study.
OBJECTIVE OBJECTIVE
The effect of monetite synthetic bone graft containing calcium pyrophosphate (Ca-PP) and β-tricalcium phosphate (β-TCP) on cervical spinal fusion in a non-instrumented two-level large animal model.
SUMMARY OF BACKGROUND DATA BACKGROUND
ACDF is the gold standard surgical technique for the treatment of degenerative cervical spinal diseases. However, pseudarthrosis associated with increased patient morbidity occurs in approximately 2,6% of the surgeries. Synthetic bone graft (SBG) may enhance bony fusion and subsequently decrease the risk of pseudarthrosis. Recent studies on monetite-based synthetic bone grafts for use in large cranial defects in humans have shown promising bone healing results, necessitating further investigation of their use in cervical spinal fusion.
METHODS METHODS
Four adult female Danish Göttingen mini-pigs received partial cervical anterior discectomy and intervertebral defects at an upper and lower level. One defect was filled with SBG and the other was left empty. Bony fusion was evaluated using computed tomography (CT) at three-month intervals for 12 months. Fifteen months post-surgery, the animals were euthanized for further ex vivo qualitative histopathological and micro-CT evaluations. Fusion rates were compared using Fisher´s exact test at each time point.
RESULTS RESULTS
Increased interbody bony fusion rates were observed at synthetic bone graft levels (4/4) compared with control levels (0/4) evaluated by CT at 6- and 9-months post-surgery (P= 0.029). Fusion was observed at all synthetic bone graft levels 12 months post-surgery and at only one control level. Histopathological evaluation confirmed high-quality interbody bony fusion at all synthetic bone graft levels, and fusion by spondylosis at one control level.
CONCLUSION CONCLUSIONS
This proof-of-concept study provides preliminary evidence of a novel, Ca-PP -and β-TCP-containing monetite SBG that promotes bony fusion compared to a negative control in a clinically relevant porcine model of ACDF.
LEVEL OF EVIDENCE METHODS
N/A.

Identifiants

pubmed: 38213106
doi: 10.1097/BRS.0000000000004916
pii: 00007632-990000000-00553
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest and Sources of funding: HE is a co-inventor of patents related to the ceramic material used in the present study. None of the remaining authors declare any conflict of interest. This study was supported by faculty funds (SLU, Swedish University of Agricultural Sciences, Uppsala, Sweden, and a U-Share grant provided by SLU and Uppsala University, Sweden) and Stiftelsen Sällskapsdjurens forskningsfond Ingeborg Ögrens fond, Sweden.

Auteurs

Maria Östman (M)

Department of Clinical Veterinary Medicine, Division of Small Animal Surgery, Vetsuisse Faculty, University of Bern, Bern, Switzerland.

Peter Försth (P)

Dept of Surgical Sciences, Division of Orthopedics, Uppsala University, Uppsala, Sweden.

Patricia Hedenqvist (P)

Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden.

Håkan Engqvist (H)

Dept of Materials Science and Engineering, Division of Applied Materials Science, Uppsala University, Uppsala, Sweden.

Leticia Marcelino (L)

University Animal Hospital, Swedish University of Agricultural Sciences, Uppsala, Sweden.

Bjørnar Ytrehus (B)

Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Norwegian Veterinary Institute, Ås, Norway.

Gry Hulsart-Billström (G)

Department of Medicinal Chemistry, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

Michael Pujari-Palmer (M)

Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden.

Caroline Öhman-Mägi (C)

Dept of Materials Science and Engineering, Division of Applied Materials Science, Uppsala University, Uppsala, Sweden.

Odd Höglund (O)

Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden.

Franck Forterre (F)

Department of Clinical Veterinary Medicine, Division of Small Animal Surgery, Vetsuisse Faculty, University of Bern, Bern, Switzerland.

Classifications MeSH